Reference sources: PubChem Epitalon (CID 219042) | NIH PMC Epitalon Overview (2025) | Wikipedia Epitalon Regulatory Notice The FDA classified Epitalon (Epitalon) as a Category 2 bulk drug substance under Section 503A guidance issued September 29, 2023, confirmed in a September 2024 update
demonstrated a doubling of plasma GSH (1530 mol/L) within 120 minutes after oral administration in rats, 7 and demonstrated dietary GSH is absorbed through a principal absorption site in the jejunum
Any court proceeding must be brought in a court with lawful jurisdiction over BGXs principal place of business, unless applicable law provides another venue
du Sert N P, Hurst V, Ahluwalia A, et al
The salt according to any one of the preceding claims, which furthermore comprises trehalose
Monitoring may include hormone panels, IGF-1, fasting glucose, A1c, inflammatory markers, symptom tracking, and assessment of recovery progress